Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Lucia Del Mastro
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Procedures
Chemicals & Drugs
Concepts & Ideas
Physiology
Sign-in to see full Profile
Network (preview)
41
Venturini, Marco
22
Garrone, Ornella
16
Rosso, Riccardo
14
Bertelli, Gianfilippo
12
Sertoli, Mario Roberto
9
Bergaglio, M
8
Lionetto, Rita
8
Pronzato, Paolo
7
Bighin, Claudia
7
Bruzzi, Paolo
6
Catzeddu, Tiziana
6
Canavese, Giuseppe
5
Contu, Antonio
5
Queirolo, Paola
4
Costantini, M
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Lucia Del Mastro (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2008: Crivellari Diana; Sun Zhuoxin; Coates Alan S; Price Karen N; Thürlimann Beat; Mouridsen Henning; Mauriac Louis; Forbes John F; Paridaens Robert J; Castiglione-Gertsch Monica; Gelber Richard D; Colleoni Marco; Láng István; Del Mastro Lucia; Gladieff Laurence; Rabaglio Manuela; Smith Ian E; Chirgwin Jacquie H; Goldhirsch Aron
Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(12):1972-9.
-
2008: Del Mastro L; Dozin B; Aitini E; Catzeddu T; Baldini E; Contu A; Durando A; Danese S; Cavazzini G; Canavese G; Bruzzi P; Pronzato P; Venturini M;
Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord-Ovest-Mammella Intergruppo (GONO-MIG) Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(2):299-307.
-
2008: Piccioli Patrizia; Serra Martina; Pedemonte Simona; Balbi Giuseppe; Loiacono Fabrizio; Lastraioli Sonia; Gargiulo Lucia; Morabito Anna; Zuccaro Daniela; Del Mastro Lucia; Pistillo Maria Pia; Venturini Marco; De Angioletti Maria; Notaro Rosario
Hexaprimer amplification refractory mutation system PCR for simultaneous single-tube genotyping of 2 close polymorphisms.
Clinical chemistry 2008;54(1):227-9.
-
2007: Clavarezza Matteo; Del Mastro Lucia; Pronzato Paolo; Bruzzi Paolo; Venturini Marco
Re: Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Journal of the National Cancer Institute 2007;99(13):1050-1; author reply 1051-2.
-
2007: Gridelli Cesare; Aapro Matti S; Barni Sandro; Beretta Giordano Domenico; Colucci Giuseppe; Daniele Bruno; Del Mastro Lucia; Di Maio Massimo; De Petris Luigi; Perrone Francesco; Thatcher Nick; De Marinis Filippo
Role of colony stimulating factors (CSFs) in solid tumours: results of an expert panel.
Critical reviews in oncology/hematology 2007;63(1):53-64.
-
2007: Coates Alan S; Keshaviah Aparna; Thürlimann Beat; Mouridsen Henning; Mauriac Louis; Forbes John F; Paridaens Robert; Castiglione-Gertsch Monica; Gelber Richard D; Colleoni Marco; Láng István; Del Mastro Lucia; Smith Ian; Chirgwin Jacquie; Nogaret Jean-Marie; Pienkowski Tadeusz; Wardley Andrew; Jakobsen Erik H; Price Karen N; Goldhirsch Aron
Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(5):486-92.
-
2006: Del Mastro Lucia; Catzeddu Tiziana; Venturini Marco
Infertility and pregnancy after breast cancer: current knowledge and future perspectives.
Cancer treatment reviews 2006;32(6):417-22.
-
2006: Del Mastro Lucia; Venturini Marco
Fertility preservation strategies for breast cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(25):4220-1; author reply 4221-2.
-
2006: Clavarezza M; Del Mastro L; Venturini M
Taxane-containing chemotherapy in the treatment of early breast cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 7():vii22-6.
-
2006: Venturini M; Bighin C; Monfardini S; Cappuzzo F; Olmeo N; Durando A; Puglisi F; Nicoletto O; Lambiase A; Del Mastro L
Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer.
Breast cancer research and treatment 2006;95(1):45-53.
-
2006: Del Mastro L; Catzeddu T; Boni L; Bell C; Sertoli M R; Bighin C; Clavarezza M; Testa D; Venturini M
Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(1):74-8.
-
2005: Venturini Marco; Del Mastro Lucia; Aitini Enrico; Baldini Editta; Caroti Cinzia; Contu Antonio; Testore Franco; Brema Fulvio; Pronzato Paolo; Cavazzini Giovanna; Sertoli Mario Roberto; Canavese Giuseppe; Rosso Riccardo; Bruzzi Paolo
Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial.
Journal of the National Cancer Institute 2005;97(23):1724-33.
-
2005: Bruzzi Paolo; Del Mastro Lucia; Sormani Maria P; Bastholt Lars; Danova Marco; Focan Christian; Fountzilas George; Paul James; Rosso Riccardo; Venturini Marco
Objective response to chemotherapy as a potential surrogate end point of survival in metastatic breast cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(22):5117-25.
-
2005: Del Mastro L; Bruzzi P; Nicolò G; Cavazzini G; Contu A; D'Amico M; Lavarello A; Testore F; Castagneto B; Aitini E; Perdelli L; Bighin C; Rosso R; Venturini Marco
HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patients.
British journal of cancer 2005;93(1):7-14.
-
2005: Del Mastro Lucia; Venturini Marco
ATAC trial update.
Lancet 2005;365(9466):1225; author reply 1225-6.
-
2005: Del Mastro L; Perrone F; Repetto L; Manzione L; Zagonel V; Fratino L; Marenco D; Venturini M; Maggi E; Bighin C; Catzeddu T; Venturino A; Rosso R;
Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(2):253-8.
-
2005: Bertelli Gianfilippo; Garrone Ornella; Merlano Marco; Occelli Marcella; Bertolotti Laura; Castiglione Federico; Pepi Fiorella; Fusco Ornella; Del Mastro Lucia; Leonard Robert C F
Sequential treatment with exemestane and non-steroidal aromatase inhibitors in advanced breast cancer.
Oncology 2005;69(6):471-7.
-
2005: Bertelli Gianfilippo; Garrone Ornella; Bertolotti Laura; Occelli Marcella; Conforti Serafino; Marzano Nicola; Febbraro Antonio; Carlini Paolo; Liossi Christina; Del Mastro Lucia; Leonard Robert C F
Maintenance hormone therapy with letrozole after first-line chemotherapy for advanced breast cancer.
Oncology 2005;68(4-6):364-70.
-
2004: Del Mastro Lucia;
[The AIOM (Italian Association of Medical Oncology) practice guidelines for breast neoplasms]
Tumori 2004;90(2):1-8.
-
2004: Catzeddu Tiziana; Bertelli Gianfilippo; Del Mastro Lucia; Venturini Marco
Sentinel lymph node biopsy in breast cancer patients: the medical oncology perspective.
Journal of surgical oncology 2004;85(3):129-32.
-
2004: Repetto Lazzaro; Comandini Danila; Mammoliti Sonia; Pietropaolo Maria; Del Mastro Lucia
Weekly paclitaxel in elderly patients with advanced breast cancer: a dose-finding study.
Drugs in R&D 2004;5(1):11-5.
-
2003: Lunardi G; Vannozzi M O; Bighin C; Del Mastro L; Stevani I; Schettini G; Venturini M
Influence of trastuzumab on epirubicin pharmacokinetics in metastatic breast cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(8):1222-6.
-
2003: Del Mastro Lucia;
[Epoetin in cancer patients. Guidelines of the ASCO and the ASH for evidence-based clinical practice]
Tumori 2003;89(4):1-12.
-
2003: Venturini Marco; Durando Antonio; Garrone Ornella; Colozza Maria Antonietta; Contu Antonio; Stevani Ilaria; Genta Franco; Bighin Claudia; Lambiase Antonio; Del Mastro Lucia
Capecitabine in combination with docetaxel and epirubicin in patients with previously untreated, advanced breast carcinoma.
Cancer 2003;97(5):1174-80.
-
2002: Bertelli G; Venturini M; Del Mastro L; Bergaglio M; Sismondi P; Biglia N; Venturini S; Porcile G; Pronzato P; Costantini M; Rosso R
Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients: a randomized study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(6):883-8.
-
2002: Venturini M; Del Mastro L; Garrone O; Angiolini C; Merlano M; Bergaglio M; Tolino G; Lambiase A; Baldini A; Canavese G; Rosso R
Phase I, dose-finding study of capecitabine in combination with docetaxel and epirubicin as first-line chemotherapy for advanced breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(4):546-52.
-
2002: Del Mastro L; Costantini M; Morasso G; Bonci F; Bergaglio M; Banducci S; Viterbori P; Conte P; Rosso R; Venturini M
Impact of two different dose-intensity chemotherapy regimens on psychological distress in early breast cancer patients.
European journal of cancer (Oxford, England : 1990) 2002;38(3):359-66.
-
2002: Del Mastro Lucia; Maggi Elisa; Catzeddu Tiziana; Hazini Abdolraim; Bell Carol
Is it possible to use anthracyclines in patients older than 70 years? Contra.
Tumori 2002;88(1 Suppl 1):S136-7.
-
2001: Venturini M; Michelotti A; Papaldo P; Del Mastro L; Bergaglio M; Lionetto R; Lunardi G; Sguotti C; Frevola L; Donati S; Rosso R; Cognetti F
Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(8):1097-106.
-
2001: Del Mastro L; Venturini M; Viscoli C; Bergaglio M; Signorini A; Bighin C; Bertelli G; Semino C; Pietra G; Bertoglio S; Sertoli M R; Lambiase A; Rosso R; Melioli G
Intensified chemotherapy supported by DMSO-free peripheral blood progenitor cells in breast cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(4):505-8.
-
2001: Del Mastro L; Venturini M; Lionetto R; Carnino F; Guarneri D; Gallo L; Contu A; Pronzato P; Vesentini L; Bergaglio M; Comis S; Rosso R
Accelerated-intensified cyclophosphamide, epirubicin, and fluorouracil (CEF) compared with standard CEF in metastatic breast cancer patients: results of a multicenter, randomized phase III study of the Italian Gruppo Oncologico Nord-Ouest-Mammella Inter Gruppo Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(8):2213-21.
-
2001: Sanguineti G; Del Mastro L; Guenzi M; Ricci P; Cavallari M; Canavese G; Stevani I; Venturini M
Impact of chemotherapy dose-density on radiotherapy dose-intensity after breast conserving surgery.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(3):373-8.
-
2001: Morasso G; Costantini M; Viterbori P; Bonci F; Del Mastro L; Musso M; Garrone O; Venturini M
Predicting mood disorders in breast cancer patients.
European journal of cancer (Oxford, England : 1990) 2001;37(2):216-23.
-
2001: Pronzato P; Queirolo P; Vecchio S; Lionetto R; Del Mastro L; Venturini M; Gardin G; Alama A; Sertoli M R
Thymidine labeling index analysis in early breast cancer patients randomized to receive perioperative chemotherapy.
Oncology 2001;60(1):88-93.
-
2000: Bertelli G; Queirolo P; Vecchio S; Angiolini C; Bergaglio M; Del Mastro L; Signorini A; Valenzano M; Venturini M
Toremifene as a substitute for adjuvant tamoxifen in breast cancer patients.
Anticancer research 2000;20(5C):3659-61.
-
2000: Venturini M; Lunardi G; Del Mastro L; Vannozzi M O; Tolino G; Numico G; Viale M; Pastrone I; Angiolini C; Bertelli G; Straneo M; Rosso R; Esposito M
Sequence effect of epirubicin and paclitaxel treatment on pharmacokinetics and toxicity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(10):2116-25.
-
2000: Michelotti A; Venturini M; Tibaldi C; Bengala C; Gallo L; Carnino F; Del Mastro L; Lionetto R; Montanaro E; Rosso R; Conte P
Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients.
Breast cancer research and treatment 2000;59(2):133-9.
-
1999: Costantini M; Musso M; Viterbori P; Bonci F; Del Mastro L; Garrone O; Venturini M; Morasso G
Detecting psychological distress in cancer patients: validity of the Italian version of the Hospital Anxiety and Depression Scale.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1999;7(3):121-7.
-
1999: Esposito M; Venturini M; Vannozzi M O; Tolino G; Lunardi G; Garrone O; Angiolini C; Viale M; Bergaglio M; Del Mastro L; Rosso R
Comparative effects of paclitaxel and docetaxel on the metabolism and pharmacokinetics of epirubicin in breast cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(4):1132.
-
1999: Del Mastro L; Venturini M
Treatment of breast cancer.
The New England journal of medicine 1999;340(4):319-20.
-
1999: Del Mastro L; Gennari A; Donati S
Chemotherapy of non-small-cell lung cancer: role of erythropoietin in the management of anemia.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10 Suppl 5():S91-4.
-
1998: Venturini M; Del Mastro L
More on dose-intensity of anthracyclines in breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(4):461.
-
1998: Dini D; Del Mastro L; Gozza A; Lionetto R; Garrone O; Forno G; Vidili G; Bertelli G; Venturini M
The role of pneumatic compression in the treatment of postmastectomy lymphedema. A randomized phase III study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(2):187-90.
-
1998: Bertelli G; Venturini M; Del Mastro L; Garrone O; Cosso M; Gustavino C; Cusimano E; Guido T; Nicolò G; Rosso R
Tamoxifen and the endometrium: findings of pelvic ultrasound examination and endometrial biopsy in asymptomatic breast cancer patients.
Breast cancer research and treatment 1998;47(1):41-6.
-
1997: Rosso R; Del Mastro L; Venturini M; Bergaglio M; Pasquetti W; Garrone O
[Use of erythropoietin in oncology]
Tumori 1997;83(4 Suppl 2):S26-30.
-
1997: Del Mastro L; Venturini M; Lionetto R; Garrone O; Melioli G; Pasquetti W; Sertoli M R; Bertelli G; Canavese G; Costantini M; Rosso R
Randomized phase III trial evaluating the role of erythropoietin in the prevention of chemotherapy-induced anemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(7):2715-21.
-
1997: Del Mastro L; Venturini M; Sertoli M R; Rosso R
Amenorrhea induced by adjuvant chemotherapy in early breast cancer patients: prognostic role and clinical implications.
Breast cancer research and treatment 1997;43(2):183-90.
-
1997: Del Mastro L; Venturini M; Costantini M; Garrone O; Sertoli M R; Bertelli G; Machì A M; Rosso R
Paradoxical effect of cytotoxic chemotherapy on anemia in cancer patients with beta-thalassemia minor.
Journal of the National Cancer Institute 1997;89(6):455-6.
-
1996: Venturini M; Michelotti A; Del Mastro L; Gallo L; Carnino F; Garrone O; Tibaldi C; Molea N; Bellina R C; Pronzato P; Cyrus P; Vinke J; Testore F; Guelfi M; Lionetto R; Bruzzi P; Conte P F; Rosso R
Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(12):3112-20.
-
1996: Venturini M; Bruzzi P; Del Mastro L; Garrone O; Bertelli G; Guelfi M; Pastorino S; Rosso R; Sertoli M R
Effect of adjuvant chemotherapy with or without anthracyclines on the activity and efficacy of first-line cyclophosphamide, epidoxorubicin, and fluorouracil in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(3):764-73.
-
1996: Venturini M; Del Mastro L; Testore F; Danova M; Garrone O; Lanfranco C; Latini F; Sertoli M R; Lionetto R; Queirolo P; Ardizzoni A; Rosso R
Erythropoietin and granulocyte-macrophage colony-stimulating factor allow acceleration and dose escalation of cyclophosphamide/epidoxorubicin/5-fluorouracil chemotherapy: a dose-finding study in patients with advanced breast cancer.
Cancer chemotherapy and pharmacology 1996;38(6):487-94.
-
1995: Bertelli G; Gozza A; Forno G B; Vidili M G; Silvestro S; Venturini M; Del Mastro L; Garrone O; Rosso R; Dini D
Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(11):2851-5.
-
1995: Sertoli M R; Bruzzi P; Pronzato P; Queirolo P; Amoroso D; Del Mastro L; Venturini M; Vigani A; Bertelli G; Campora E
Randomized cooperative study of perioperative chemotherapy in breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(11):2712-21.
-
1995: Del Mastro L; Venturini M; Giannessi P G; Vigani A; Garrone O; Carnino F; Russo P; Galletti P; Rosso R; Conte P F
Intraperitoneal infusion of recombinant human tumor necrosis factor and mitoxantrone in neoplastic ascites: a feasibility study.
Anticancer research 1995;15(5B):2207-12.
-
1994: Venturini M; Del Mastro L; Melioli G; Balleari E; Garrone O; Pasquetti W; Bason C; Ghio R; Bruzzi P; Rosso R
Release of peripheral blood progenitor cells during standard dose cyclophosphamide, epidoxorubicin, 5-fluorouracil regimen plus granulocyte colony stimulating factor for breast cancer therapy.
Cancer 1994;74(8):2300-6.
-
1994: Del Mastro L; Garrone O; Guenzi M; Cafiero F; Nicolò G; Rosso R; Venturini M
Angiosarcoma of the residual breast after conservative surgery and radiotherapy for primary carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(2):163-5.
-
1994: Del Mastro L; Garrone O; Sertoli M R; Canavese G; Catturich A; Guenzi M; Rosso R; Venturini M
A pilot study of accelerated cyclophosphamide, epirubicin and 5-fluorouracil plus granulocyte colony stimulating factor as adjuvant therapy in early breast cancer.
European journal of cancer (Oxford, England : 1990) 1994;30A(5):606-10.
-
1993: Venturini M; Del Mastro L; Ardizzoni A; Sertoli M R; Mariani G L; Pennucci M C; Garrone O; Silvestro S; Addamo G F; Queirolo P
High dose intensity chemotherapy without bone marrow support: role of granulocyte-macrophage colony-stimulating factor.
Annals of the New York Academy of Sciences 1993;698():389-97.
-
1993: Garrone O; Del Mastro L; Mariani G L; Ardizzoni A; Venturini M; Rosso R
[Feasibility of a cyclophosphamide methotrexate and 5-fluorouracil regime intravenously administered with and without granulocyte-colony stimulating factor in surgically treated breast carcinoma]
Minerva medica 1993;84(9):467-72.
Sign-in to see more
